Mallinckrodt Plc (NYSE:MNK)

122.01
Delayed Data
As of Apr 24
 -2.84 / -2.27%
Today’s Change
65.69
Today|||52-Week Range
134.26
+23.21%
Year-to-Date

Today’s Trading

Previous close124.85
Today’s open124.15
Day’s range121.71 - 124.65
Volume946,082
Average volume (3 months)1,283,029
Market cap$14.5B
Dividend yield--
Data as of 4:03pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+46.82%
Earnings growth (next 5 years)+17.80%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc-0.05-0.06%
ENDPEndo International P...-0.81-0.86%
JAZZJazz Pharmaceuticals...+0.33+0.17%
INCYIncyte Corp-0.51-0.47%
Data as of 4:01pm ET, 04/24/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$1.54
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers